Patents-Review.com
🔗 Permalink
Assignee profile:

MICROMET AG

City:

Munich

Country:

Germany

Published Applications:

26

Last publication date:

2014-08-28

Patent Grants:

23

Last grant date:

2014-09-23

Top Inventors for applications by MICROMET AG

These are the the leading inventors for applications assigned to MICROMET AG:

Recent patent applications by MICROMET AG

MICROMET AG based in Munich, DE has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2014-08-28
US20140242081A1
Chemistry; metallurgy

DOSING REGIMENS FOR TREATMENT OF CEA-EXPRESSING CANCERS

 #2 | 2012-12-27 ✅ Patent 8,840,888 granted on 2014-09-23
US20120328618A1
Chemistry; metallurgy

Dosage regimen for administering a CD19XCD3 bispecific antibody

 #3 | 2012-01-12 ✅ Patent 9,067,993 granted on 2015-06-30
US20120009195A1
Chemistry; metallurgy

Antibody neutralizers of human granulocyte macrophage colony stimulating factor

 #4 | 2010-10-26 ✅ Patent 7,820,166 granted on 2010-10-26
US10682845
-

Potent T cell modulating molecules

 #5 | 2010-07-22
US20100183615A1
Chemistry; metallurgy

CROSS-SPECIES-SPECIFIC BISPECIFIC BINDERS

 #6 | 2010-06-17
US20100150918A1
Chemistry; metallurgy

CROSS-SPECIES-SPECIFIC BINDING DOMAIN

 #7 | 2009-12-10 ✅ Patent 7,976,842 granted on 2011-07-12
US20090304716A1
Human necessities

Treatment of metastatic breast cancer

 #8 | 2009-12-03 ✅ Patent 8,017,748 granted on 2011-09-13
US20090297532A1
Chemistry; metallurgy

Antibody neutralizers of human granulocyte macrophage colony stimulating factor

 #9 | 2009-11-26 ✅ Patent 8,007,796 granted on 2011-08-30
US20090291072A1
Human necessities

Means and methods for the treatment of tumorous diseases

 #10 | 2009-10-08 ✅ Patent 8,236,308 granted on 2012-08-07
US20090252683A1
Human necessities

Composition comprising cross-species-specific antibodies and uses thereof

 #11 | 2009-09-10 ✅ Patent 8,394,926 granted on 2013-03-12
US20090226432A1
Chemistry; metallurgy

Pharmaceutical compositions with resistance to soluble CEA

 #12 | 2009-03-26 ✅ Patent 7,632,925 granted on 2009-12-15
US20090081191A1
Chemistry; metallurgy

Antibodies that bind human 17-A1/EpCAM tumor antigen

 #13 | 2009-01-22 ✅ Patent 8,076,459 granted on 2011-12-13
US20090022738A1
Human necessities

Multispecfic deimmunized CD3-binders

 #14 | 2008-12-25 ✅ Patent 7,964,707 granted on 2011-06-21
US20080317746A1
Chemistry; metallurgy

Anti-IL2 antibodies

 #15 | 2008-10-14 ✅ Patent 7,435,549 granted on 2008-10-14
US9554465
-

Method of identifying binding site domains that retain the capacity of binding to an epitope

 #16 | 2008-09-04 ✅ Patent 8,101,722 granted on 2012-01-24
US20080213256A1
Chemistry; metallurgy

Less immunogenic binding molecules

 #17 | 2008-08-14 ✅ Patent 8,247,194 granted on 2012-08-21
US20080193978A1
Chemistry; metallurgy

Preparation of scFv antibody fragments

 #18 | 2008-02-19 ✅ Patent 7,332,168 granted on 2008-02-19
US10362591
-

Composition for the elimination of autoreactive B-cells

 #19 | 2007-06-12 ✅ Patent 7,229,760 granted on 2007-06-12
US10239518
-

mRNA amplification

 #20 | 2007-06-05 ✅ Patent 7,227,002 granted on 2007-06-05
US9403107
-

Human antibodies that bind human 17-A1/EpCAM tumor antigen

 #21 | 2007-04-12 ✅ Patent 7,919,089 granted on 2011-04-05
US20070081993A1
Chemistry; metallurgy

Pharmaceutical composition comprising a bispecific antibody for EpCAM

 #22 | 2006-09-26 ✅ Patent 7,112,324 granted on 2006-09-26
US9673735
-

CD 19×CD3 specific polypeptides and uses thereof

 #23 | 2006-09-12 ✅ Patent 7,105,638 granted on 2006-09-12
US8014096
-

Product and process for the production, isolation, and purification of recombinant polypeptide

 #24 | 2006-08-31 ✅ Patent 7,575,923 granted on 2009-08-18
US20060193852A1
Chemistry; metallurgy

CD19xCD3 specific polypeptides and uses thereof

 #25 | 2006-03-23 ✅ Patent 7,323,440 granted on 2008-01-29
US20060062780A1
Chemistry; metallurgy

De-immunized MOG (poly)peptide constructs

 #26 | 2005-06-23 ✅ Patent 7,235,641 granted on 2007-06-26
US20050136050A1
Chemistry; metallurgy

Bispecific antibodies
AssigneeID:

76239 ⎘